Solmetex, founded in 1994, began as a dental water-treatment specialist focused on removing mercury waste from dental offices. Over time the company has expanded its portfolio to include amalgam separation, waterline safety solutions, dental isolation technology, and regenerative biomaterials. Today it supplies more than 85,000 dental offices across the United States, positioning itself as a comprehensive provider in the dental supply chain. Growth has been accelerated through strategic acquisitions that add complementary technologies to its platform. With CEO Gene Dorff at the helm, the company plans to continue scaling both organically and via additional M&A. Backing from private-equity sponsors is intended to strengthen its market position and fund high-impact growth initiatives. No revenue or profitability figures were disclosed in the article.

Total raised

$200M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2025